Trial watch: Impact of genetically supported target selection on R&D productivity
Nat Rev Drug Discov
.
2016 Aug 30;15(9):596-597.
doi: 10.1038/nrd.2016.164.
Authors
Mark R Hurle
1
,
Matthew R Nelson
1
,
Pankaj Agarwal
1
,
Lon R Cardon
1
Affiliation
1
GlaxoSmithKline, 709 Swedeland Rd, UW2230, King of Prussia, Pennsylvania 19406, USA.
PMID:
27573226
DOI:
10.1038/nrd.2016.164
No abstract available
MeSH terms
Biomedical Research / economics
Clinical Trials, Phase I as Topic / economics
Drug Delivery Systems / methods*
Humans
Pharmacogenetics*